+143.3%
MRNA vs DOV
-6.0%
+149.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | DOV | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -1.7% | -1.7% | -3.4% |
| 7D | -10.1% | +1.3% | -11.4% | -10.0% |
| 30D | +126.7% | -8.6% | +135.4% | +127.6% |
| 3M | +184.1% | -13.1% | +197.3% | +181.9% |
| 6M | +143.3% | -8.8% | +152.1% | +131.1% |
| All | +143.3% | -6.0% | +149.3% | +131.1% |
Cumulative growth
Daily Returns
Daily percentage return beside DOV.
Daily Out/Under-Performance
Portfolio return minus DOV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DOV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded DOV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling